Advanced search
Publication Cover
Expert Opinion on Pharmacotherapy Volume 6, 2005 - Issue 13
Submit an article Journal homepage
50
Views
17
CrossRef citations to date
0
Altmetric
Review

Targeting the renin-angiotensin-aldosterone-system in atrial fibrillation: a shift from electrical to structural therapy?

Anirban Choudhury Haemostasis, Thrombosis and Vascular Biology Unit, University Department of Medicine, City Hospital, Birmingham B18 7QH, UK. [email protected]
,
George I Varughese Haemostasis, Thrombosis and Vascular Biology Unit, University Department of Medicine, City Hospital, Birmingham B18 7QH, UK. [email protected]
&
Gregory YH Lip Haemostasis, Thrombosis and Vascular Biology Unit, University Department of Medicine, City Hospital, Birmingham B18 7QH, UK. [email protected]
Pages 2193-2207 | Published online: 12 Oct 2005

Citations (17)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (2)

Cesare Cuspidi, Francesca Negri & Alberto Zanchetti. (2008) Angiotensin II receptor blockers and cardiovascular protection: Focus on left ventricular hypertrophy regression and atrial fibrillation prevention. Vascular Health and Risk Management 4:1, pages 67-73.
Read now
Piotr Rucinski, Andrzej Rubaj & Andrzej Kutarski. (2006) Pharmacotherapy changes following pacemaker implantation in patients with bradycardia–tachycardia syndrome. Expert Opinion on Pharmacotherapy 7:16, pages 2203-2213.
Read now

Articles from other publishers (15)

Ahsan A Khan & Gregory Y H Lip. (2019) The prothrombotic state in atrial fibrillation: pathophysiological and management implications. Cardiovascular Research 115:1, pages 31-45.
Crossref
Siva K. Mulpuru, Alejandro A. Rabinstein & Samuel J. Asirvatham. (2014) Atrial Fibrillation and Stroke. Cardiac Electrophysiology Clinics 6:1, pages 31-41.
Crossref
Cesare Cuspidi, Francesca Negri, Maria Lorenza Muiesan, Anna Maria Grandi, Laura Lonati, Antonello Ganau, Daniela Degli Esposti, Alberto Milan, Carla Sala, Rita Facchetti & Giuseppe Mancia. (2011) Indexing cardiac parameters in echocardiographic practice: Do estimates depend on how weight and height have been assessed? A study on left atrial dilatation. Journal of the American Society of Hypertension 5:3, pages 177-183.
Crossref
Arun Sridhar, Yoshinori Nishijima, Dmitry Terentyev, Mahmood Khan, Radmila Terentyeva, Robert L. Hamlin, Tomohiro Nakayama, Sandor Gyorke, Arturo J. Cardounel & Cynthia A. Carnes. (2009) Chronic heart failure and the substrate for atrial fibrillation. Cardiovascular Research 84:2, pages 227-236.
Crossref
B. Solun, D. Marcoviciu & D. Dicker. (2009) Does treatment of hypertension decrease the incidence of atrial fibrillation and cardioembolic stroke?. European Journal of Internal Medicine 20:2, pages 125-131.
Crossref
Timothy Watson, Eduard Shantsila & Gregory YH Lip. (2009) Mechanisms of thrombogenesis in atrial fibrillation: Virchow's triad revisited. The Lancet 373:9658, pages 155-166.
Crossref
David R. Van Wagoner & Stanley Nattel. (2008) Insights into mechanisms linking cardiac hypertrophy and atrial fibrosis: Evidence for a role of histone deacetylase in atrial fibrillation pathophysiology and therapy. Journal of Molecular and Cellular Cardiology 45:6, pages 707-708.
Crossref
Offer Amir, Ruthie E. Amir, Hagar Paz, Roi Mor, Michael Sagiv & Basil S. Lewis. (2008) Aldosterone Synthase Gene Polymorphism as a Determinant of Atrial Fibrillation in Patients With Heart Failure. The American Journal of Cardiology 102:3, pages 326-329.
Crossref
K-H Yiu & H-F Tse. (2008) Hypertension and cardiac arrhythmias: a review of the epidemiology, pathophysiology and clinical implications. Journal of Human Hypertension 22:6, pages 380-388.
Crossref
B. A. Tatarskyi. (2007) Application of an angiotensin)converting enzyme inhibitor zofenopril in patients with paroxismal form of atrial fibrillation. "Arterial’naya Gipertenziya" ("Arterial Hypertension") 13:3, pages 197-201.
Crossref
S. Rangan, P. K. Singh, A. A. Tahrani & G. I. Varughese. (2007) Diabetes mellitus and cardiovascular risk factors: more insights revisited. International Journal of Clinical Practice 61:6, pages 1055-1056.
Crossref
G. Y. H. Lip, L. Frison & M. Grind. (2007) Angiotensin converting enzyme inhibitor and angiotensin receptor blockade use in relation to outcomes in anticoagulated patients with atrial fibrillation. Journal of Internal Medicine 261:6, pages 577-586.
Crossref
Robert M. Carey. 2007. Comprehensive Hypertension. Comprehensive Hypertension 299 315 .
G. I. Varughese & J. H. B. Scarpello. (2006) Response to: Angiotensin receptor blockers in hypertension: the emerging role in diabetes mellitus. International Journal of Clinical Practice 60:8, pages 1010-1012.
Crossref
C J Boos & G Y H Lip. (2005) Targeting the renin–angiotensin–aldosterone system in atrial fibrillation: from pathophysiology to clinical trials. Journal of Human Hypertension 19:11, pages 855-859.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.